drugset / Trial / NCT04680221

Stopping Opioid Overuse in Obstetrics to Halt Exposure Trial

NCT04680221 ↗

Phase 4 Active not recruiting 97 enrolled University of Missouri, Kansas City Truman Medical Center · collab
RandomizedParallel-groupTriple-blindTreatment

Summary

As the opioid epidemic continues on, more research is needed on multi-modal approaches to decrease opioid exposure after common procedures. The aim of this study is to investigate the role of a transverses abdominis block using liposome bupivacaine suspension in reducing use of opioid medications through post-operative day 7. The study is a proposed double-blind, randomized controlled trial.

Timeline

Start
2021-03-01
Primary completion
2025-06-01
Completion
2025-06-01

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bupivacaine Other / unclassified 266 mg Other